Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of an MMP Inhibitor, Doxycycline, to Reduce Ovarian Androgen Production and Restore Normal Cycling in Women With Polycystic Ovarian Syndrome

NCT01788215 is registered in ClinicalTrials.gov with University of Rochester as lead sponsor.

NCT NCT01788215
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01788215 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of an MMP Inhibitor, Doxycycline, to Reduce Ovarian Androgen Production and Restore Normal Cycling in Women With Polycystic Ovarian Syndrome
Lead sponsor
University of Rochester
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2010
Completion date
September 30, 2014
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

androgen excess, irregular menstrual cycles, polycystic ovarian syndrome (pcos)